Myeloma XI trial: impact of MRD on treatment response in MM
A "chemo-sparing" MRD-driven strategy for CLL
The TAP CLARITY study: latest results and future plans
Making cancer treatments more affordable
How can clinicians and nurses care for patients with oral graft-versus-host disease (GvHD)?